These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26069074)
1. Circulating insulin-like growth factor binding protein-3 predicts one-year outcome after ischemic stroke. Ebinger M; Ipsen N; Leonards CO; Empl L; Hanne L; Liman T; Mai K; Strasburger CJ; Spranger J; Endres M Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):461-5. PubMed ID: 26069074 [TBL] [Abstract][Full Text] [Related]
2. Circulating Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 predict Three-months Outcome after Ischemic Stroke. Armbrust M; Worthmann H; Dengler R; Schumacher H; Lichtinghagen R; Eschenfelder CC; Endres M; Ebinger M Exp Clin Endocrinol Diabetes; 2017 Jul; 125(7):485-491. PubMed ID: 28724170 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I serum levels influence ischemic stroke outcome. De Smedt A; Brouns R; Uyttenboogaart M; De Raedt S; Moens M; Wilczak N; Luijckx GJ; De Keyser J Stroke; 2011 Aug; 42(8):2180-5. PubMed ID: 21700939 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Denti L; Annoni V; Cattadori E; Salvagnini MA; Visioli S; Merli MF; Corradi F; Ceresini G; Valenti G; Hoffman AR; Ceda GP Am J Med; 2004 Sep; 117(5):312-7. PubMed ID: 15336580 [TBL] [Abstract][Full Text] [Related]
5. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182 [TBL] [Abstract][Full Text] [Related]
6. Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational study. Åberg ND; Åberg D; Jood K; Nilsson M; Blomstrand C; Kuhn HG; Svensson J; Jern C; Isgaard J BMC Neurol; 2018 Aug; 18(1):106. PubMed ID: 30081862 [TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke. Johnsen SP; Hundborg HH; Sørensen HT; Orskov H; Tjønneland A; Overvad K; Jørgensen JO J Clin Endocrinol Metab; 2005 Nov; 90(11):5937-41. PubMed ID: 16131586 [TBL] [Abstract][Full Text] [Related]
8. Decrease in Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-1 Ratio in the First Week of Stroke Is Related to Positive Outcomes. Mattlage AE; Rippee MA; Sandt J; Billinger SA J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1800-1806. PubMed ID: 27113779 [TBL] [Abstract][Full Text] [Related]
9. Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome. Bondanelli M; Ambrosio MR; Onofri A; Bergonzoni A; Lavezzi S; Zatelli MC; Valle D; Basaglia N; degli Uberti EC J Clin Endocrinol Metab; 2006 Oct; 91(10):3928-34. PubMed ID: 16882751 [TBL] [Abstract][Full Text] [Related]
10. Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury. Schwab S; Spranger M; Krempien S; Hacke W; Bettendorf M Stroke; 1997 Sep; 28(9):1744-8. PubMed ID: 9303019 [TBL] [Abstract][Full Text] [Related]
11. Estimated Prestroke Peak VO2 Is Related to Circulating IGF-1 Levels During Acute Stroke. Mattlage AE; Rippee MA; Abraham MG; Sandt J; Billinger SA Neurorehabil Neural Repair; 2017 Jan; 31(1):65-71. PubMed ID: 27377914 [TBL] [Abstract][Full Text] [Related]
17. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide. Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342 [TBL] [Abstract][Full Text] [Related]
18. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Schernhammer ES; Holly JM; Pollak MN; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication does not change circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 levels in patients with and without precancerous gastric lesions. Ustundag Y; Sahin H; İlikhan S; Dogan BG; Kokturk F; Kar F Am J Med Sci; 2013 Nov; 346(5):381-4. PubMed ID: 23276902 [TBL] [Abstract][Full Text] [Related]
20. Intravenous tissue plasminogen activator in patients with stroke increases the bioavailability of insulin-like growth factor-1. Wilczak N; Elting JW; Chesik D; Kema IP; De Keyser J Stroke; 2006 Sep; 37(9):2368-71. PubMed ID: 16902174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]